Subject(s)

Antineoplastic Agents, Immunological/therapeutic use , Immunotherapy, Adoptive , Molecular Targeted Therapy , Multiple Myeloma/immunology , Multiple Myeloma/therapy , Antineoplastic Agents, Immunological/administration & dosage , Antineoplastic Agents, Immunological/adverse effects , Combined Modality Therapy/adverse effects , Combined Modality Therapy/methods , Drug Resistance, Neoplasm , Female , Humans , Immunotherapy, Adoptive/adverse effects , Immunotherapy, Adoptive/methods , Male , Middle Aged , Multiple Myeloma/diagnosis , Recurrence , Retreatment , Treatment Outcome